Literature DB >> 23743687

Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.

Regina G H Beets-Tan1, Doenja M J Lambregts, Monique Maas, Shandra Bipat, Brunella Barbaro, Filipe Caseiro-Alves, Luís Curvo-Semedo, Helen M Fenlon, Marc J Gollub, Sofia Gourtsoyianni, Steve Halligan, Christine Hoeffel, Seung Ho Kim, Andrea Laghi, Andrea Maier, Søren R Rafaelsen, Jaap Stoker, Stuart A Taylor, Michael R Torkzad, Lennart Blomqvist.   

Abstract

OBJECTIVES: To develop guidelines describing a standardised approach regarding the acquisition, interpretation and reporting of magnetic resonance imaging (MRI) for clinical staging and restaging of rectal cancer.
METHODS: A consensus meeting of 14 abdominal imaging experts from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) was conducted following the RAND-UCLA Appropriateness Method. Two independent (non-voting) chairs facilitated the meeting. Two hundred and thirty-six items were scored by participants for appropriateness and classified subsequently as appropriate or inappropriate (defined by ≥ 80 % consensus) or uncertain (defined by < 80 % consensus). Items not reaching 80 % consensus were noted.
RESULTS: Consensus was reached for 88 % of items: recommendations regarding hardware, patient preparation, imaging sequences, angulation, criteria for MRI assessment and MRI reporting were constructed from these.
CONCLUSIONS: These expert consensus recommendations can be used as clinical guidelines for primary staging and restaging of rectal cancer using MRI. KEY POINTS: • These guidelines recommend standardised imaging for staging and restaging of rectal cancer. • The guidelines were constructed through consensus amongst 14 abdominal imaging experts. • Consensus was reached by in 88 % of 236 items discussed.

Entities:  

Mesh:

Year:  2013        PMID: 23743687     DOI: 10.1007/s00330-013-2864-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  B Glimelius; L Påhlman; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Morphological assessment of the interface between tumor and neighboring tissues, by magnetic resonance imaging, before and after radiotherapy in patients with locally advanced rectal cancer.

Authors:  M R Torkzad; C Suzuki; S Tanaka; G Palmer; T Holm; L Blomqvist
Journal:  Acta Radiol       Date:  2008-12       Impact factor: 1.990

3.  Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.

Authors:  I Song; S H Kim; S J Lee; J Y Choi; M J Kim; H Rhim
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

4.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

5.  Diffusion-weighted magnetic resonance imaging for detecting lymph node metastasis of rectal cancer.

Authors:  Yo Mizukami; Shugo Ueda; Akiyoshi Mizumoto; Tetsuro Sasada; Ryosuke Okumura; Shigene Kohno; Arimichi Takabayashi
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

6.  Fusion of high b-value diffusion-weighted and T2-weighted MR images improves identification of lymph nodes in the pelvis.

Authors:  N Mir; S A Sohaib; D Collins; D M Koh
Journal:  J Med Imaging Radiat Oncol       Date:  2010-08       Impact factor: 1.735

7.  Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison.

Authors:  Gina Brown; Catherine J Richards; Michael W Bourne; Robert G Newcombe; Andrew G Radcliffe; Nicholas S Dallimore; Geraint T Williams
Journal:  Radiology       Date:  2003-05       Impact factor: 11.105

8.  High-resolution MRI of the anatomy important in total mesorectal excision of the rectum.

Authors:  Gina Brown; Alex Kirkham; Geraint T Williams; Michael Bourne; Andrew G Radcliffe; Joanne Sayman; Richard Newell; Chummy Sinnatamby; Richard J Heald
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

9.  A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy.

Authors:  G Lezoche; M Baldarelli; Mario Guerrieri; A M Paganini; A De Sanctis; S Bartolacci; E Lezoche
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

10.  The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer.

Authors:  Dow-Mu Koh; Neil J Smith; R Ian Swift; Gina Brown
Journal:  Clin Med Oncol       Date:  2008-04-01
View more
  85 in total

1.  The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Jing Yu; Qing Xu; Jia-Cheng Song; Yan Li; Xin Dai; Dong-Ya Huang; Ling Zhang; Yang Li; Hai-Bin Shi
Journal:  Eur Radiol       Date:  2016-09-08       Impact factor: 5.315

2.  The influence of endorectal filling on rectal cancer staging with MRI.

Authors:  Rutger Ch Stijns; Tom Wj Scheenen; Johannes Hw de Wilt; Jurgen J Fütterer; Regina Gh Beets-Tan
Journal:  Br J Radiol       Date:  2018-06-14       Impact factor: 3.039

Review 3.  Adaptive radiation dose escalation in rectal adenocarcinoma: a review.

Authors:  Jonathan D Van Wickle; Eric S Paulson; Jerome C Landry; Beth A Erickson; William A Hall
Journal:  J Gastrointest Oncol       Date:  2017-10

Review 4.  MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.

Authors:  Xavier Druet; Estrella Acosta Sanchez; Ken Soleakhena; Anne Laprie; Jordi Sáez; Stéphanie Nougaret; Olivier Riou; Elodie Rigal; Laura Kibranian; Miguel Palacios; Ismael Membrive
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-05

5.  Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.

Authors:  Doenja M J Lambregts; Miriam M van Heeswijk; Andrea Delli Pizzi; Saskia G C van Elderen; Luisa Andrade; Nicky H G M Peters; Peter A M Kint; Margreet Osinga-de Jong; Shandra Bipat; Rik Ooms; Max J Lahaye; Monique Maas; Geerard L Beets; Frans C H Bakers; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

Review 6.  MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management.

Authors:  Natally Horvat; Camila Carlos Tavares Rocha; Brunna Clemente Oliveira; Iva Petkovska; Marc J Gollub
Journal:  Radiographics       Date:  2019-02-15       Impact factor: 5.333

Review 7.  Imaging Procedures for Colorectal Cancer.

Authors:  Bettina Baeßler; David Maintz; Thorsten Persigehl
Journal:  Visc Med       Date:  2016-06-08

8.  Discrimination of metastatic from non-metastatic mesorectal lymph nodes in rectal cancer using quantitative dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Xiao-Ping Yu; Lu Wen; Jing Hou; Hui Wang; Qiang Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

9.  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.

Authors:  Hale Çolakoğlu Er; Elif Peker; Ayşe Erden; İlhan Erden; Ethem Geçim; Berna Savaş
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

10.  SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.

Authors:  R García-Carbonero; R Vera; F Rivera; E Parlorio; M Pagés; E González-Flores; C Fernández-Martos; M Á Corral; R Bouzas; F Matute
Journal:  Clin Transl Oncol       Date:  2016-05-20       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.